37 results on '"Buck, Andreas K."'
Search Results
2. C-X-C Motif Chemokine Receptor 4–Targeted Radioligand Therapy in Hematological Malignancies—Myeloablative Effects, Antilymphoma Activity, and Safety Profile
3. Impact of CXCR4-Directed PET/CT on Staging and Proposed Oncologic Management in Patients With Digestive System Tumors
4. High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
5. Complete Remission Upon Peptide Receptor Radionuclide Therapy in a G2 Pancreatic Neuroendocrine Tumor
6. Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer
7. Complete Remission Upon Peptide Receptor Radionuclide Therapy in a G2 Pancreatic Neuroendocrine Tumor
8. Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
9. Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors
10. Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed Endoradiotherapy
11. Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor–Directed Molecular Imaging and Therapy
12. Impact of aging on semiquantitative uptake parameters in normal rated clinical baseline [123I]Ioflupane single photon emission computed tomography/computed tomography
13. Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma
14. Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging
15. Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging
16. Chemokine Receptor 4 Expression in Primary Sjögren’s Syndrome
17. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer
18. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma
19. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients
20. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
21. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms
22. Pretherapeutic estimation of kidney function in patients treated with peptide receptor radionuclide therapy: can renal scintigraphy be safely omitted?
23. Freehand SPECT-guided sentinel lymph node biopsy in early oral squamous cell carcinoma
24. Early development of a celiac trunk aneurysm during anti-vascular endothelial growth factor receptor therapy
25. PET Tracers in Musculoskeletal Disease beyond FDG
26. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
27. [123I]Iodometomidate Imaging in Adrenocortical Carcinoma
28. Functional Characterization of Adrenal Lesions Using [123I]IMTO-SPECT/CT
29. 18F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma
30. Life Expectancy Is Reduced in Differentiated Thyroid Cancer Patients ≥ 45 Years Old with Extensive Local Tumor Invasion, Lateral Lymph Node, or Distant Metastases at Diagnosis and Normal in All Other DTC Patients
31. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma
32. [131I]Iodometomidate for Targeted Radionuclide Therapy of Advanced Adrenocortical Carcinoma
33. Facing the Nuclear Threat: Thyroid Blocking Revisited
34. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study
35. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast-enhanced ultrasound, three-phase helical CT and [18F]fluorodeoxyglucose positron-emission tomography
36. 188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study
37. Internal radionuclide therapy: The ULMDOS software for treatment planning
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.